Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 52, 2023 - Issue 2
86
Views
0
CrossRef citations to date
0
Altmetric
Research Article

No Association Between Interleukin 6 and Inducible Nitric Oxide Synthase Polymorphisms and Dengue Infection: A Case-Control Study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all

References

  • Abhishek KS, Chakravarti A, Baveja CP, Kumar N, Siddiqui O, Kumar S. 2017. Association of interleukin-2, -4 and -10 with dengue severity. Indian J Pathol Microbiol. 60(1):66–69.
  • Abrão MG, Billerbeck AEC, Nishi MY, Marui S, De Mendonça BB. 2005. [Standardization of DNA extraction with NaCl from oral mucosa cells: application in PROP1 gene study]. Arq Bras Endocrinol Metabol. 49(6):978–82.
  • Allen JE, Wynn TA. 2011. Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathogen. (5):e1002003. doi:10.1371/journal.ppat.1002003
  • Avendaño-Tamayo E, Campo O, Chácon-Duque JC, Ramírez R, Rojas W, Agudelo-Flórez P, Bedoya G, Restrepo BN. 2017. [Variants in the TNFA, IL6 and IFNG genes are associated with the dengue severity in a sample from Colombian population]. Biomedica. 37(4):486–97.
  • Bibert S, Bratschi MW, Aboagye SY, Collinet E, Scherr N, Yeboah-Manu D, Beuret C, Pluschke G, Bochud P-Y. 2017. Susceptibility to Mycobacterium ulcerans disease (Buruli ulcer) is associated with IFNG and iNOS gene polymorphisms. Front Microbiol. 8(1903): 1–10.
  • Butthep P, Chunhakan S, Yoksan S, Tangnararatchakit K, Chuansumrit A. 2012. Alteration of cytokines and chemokines during febrile episodes associated with endothelial cell damage and plasma leakage in dengue hemorrhagic fever. Pediatr Infect Dis. 31(12):e232–38.
  • De La Cruz Hernández SI, Puerta-Guardo HN, Flores HA, González SM, López IM, Ortiz-Navarrete V, Ludert JE, Del Angel RM. 2016. Primary dengue virus infections induce differential cytokine production in Mexican patients. Memórias Do Instituto Oswaldo Cruz. 111(3):161–67.
  • Dettogni RS, Tristão-Sá R, Dos Santos M, Da Silva FF, Louro ID. 2015. Single nucleotide polymorphisms in immune system genes and their association with clinical symptoms persistence in dengue-infected persons. Hum Immunol. 76(10):717–23.
  • Dzodzomeny M, Ghansah A, Ensaw N, Dovie B, Bimi L, Quansah R, Gyan BA, Gyakobo M, Amoani B. 2018. Inducible nitric oxide synthase 2 promoter polymorphism and malaria disease severity in children in Southern Ghana. Plos One. 13(8):e0202218.
  • Eppy E, Suhendro S, Nainggolan L, Rumende CM. 2016. The differences between interleukin-6 and c-reactive protein levels among adult patients of dengue infection with and without plasma leakage. Acta Med Indones. 48(1):3–9.
  • Feitosa RNM, Vallinoto ACR, Vasconcelos PFC, Azevedo RSS, Azevedo VN, Machado LFA, Lima SS, Ishak MDOG, Ishak R. 2016. Gene polymorphisms and serum levels of pro- and anti-inflammatory markers in dengue viral infections. Viral Immunol. 29(7):379–88.
  • Fialho LG, Torrentes-Carvalho A, Cunha RV, Faria N, Gandini M, Cipitelli M, de-Oliveira-Pinto LM, Azeredo EL, Kubelka CF. 2017. Induced nitric oxide synthase (iNOS) and indoleamine 2,3-dioxygenase (IDO) detection in circulating monocyte subsets from Brazilian patients with Dengue-4 virus. Virol Rep. 7:9–19.
  • Flores-Mendoza LK, Estrada-Jiménez T, Sedeño-Monge V, Moreno M, Manjarrez MDC, González-Ochoa G, Millán-Pérez Peña L, Reyes-Leyva J. 2017. IL-10 and socs3 are predictive biomarkers of dengue hemorrhagic fever. Mediators Inflamm. 2017:1–10.
  • Förstermann U, Sessa WC. 2012. Nitric oxide synthases: regulation and function. Eur Heart J. 33(7):829–37.
  • Guan Y, Wang S, Wang J, Meng D, Wu H, Wei Q, Jiang H. 2020. Gene polymorphisms and expression levels of interleukin-6 and interleukin-10 in lumbar disc disease: a meta-analysis and immunohistochemical study. J Orthop Surg Res. 15(54):1–11.
  • Hapugaswatta H, Wimalasekara RL, Perera SS, Premaratna R, Seneviratne KN, Jayathilaka N. 2021. Expression of nitric oxide synthase and nitric oxide levels in peripheral blood cells and oxidized low-density lipoprotein levels in saliva as early markers of severe dengue. Biomed Res Int. 2021:1–9.
  • Hirano T. 2021. IL-6 in inflammation, autoimmunity and cancer. Inter Immunol. 33(3):127–48.
  • Hobbs MR, Udhayakumar V, Levesque MC, Booth J, Roberts JM, Tkachuk AN, Pole A, Coon H, Kariuki S, Nahlen BL, et al. 2002. A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Lancet. 360(9344):1468–75.
  • Imad HA, Phumratanaprapin W, Phonrat B, Chotivanich K, Charunwatthana P, Muangnoicharoen S, Khusmith S, Tantawichien T, Phadungsombat J, Nakayama E, et al. 2020. Cytokine expression in dengue fever and dengue hemorrhagic fever patients with bleeding and severe hepatitis. Am J Trop Med Hyg. 102(5):943–50.
  • Jing Q, Wang M. 2019. Dengue epidemiology. Glob Health J. 3(2):37–45.
  • Kumar Y, Liang C, Bo Z, Rajapakse JC, Ooi EE, Tannenbaum SR. 2012. Serum proteome and cytokine analysis in a longitudinal cohort of adults with primary dengue infection reveals predictive markers of DHF. PLoS Negl Trop Dis. 6(11):e1887.
  • Kumar A, Singh KP, Bali P, Anwar S, Kaul A, Singh OP, Gupta BK, Kumari N, Noor Alam M, Raziuddin M, et al. 2018. iNOS polymorphism modulates iNOS/NO expression via impaired antioxidant and ROS content in P. vivax and P. falciparum infection. Redox Biol. 15:192–206.
  • Leonidou A, Lepetsos P, Kenanidis E, Macheras G, Tzetis M, Potoupnis M, Tsiridis E, et al. 2020. Association of polymorphisms in the promoter region of NOS2A gene with primary knee osteoarthritis in the Greek population. Cureus. 12(1): e6780.
  • Levy A, Valero N, Espina LM, Añez G, Arias J, Mosquera J. 2010. Increment of interleukin 6, tumour necrosis factor alpha, nitric oxide, C-reactive protein and apoptosis in dengue. Trans R Soc Trop Med Hyg. 104(1):16–23.
  • Mapalagamage M, Handunnetti S, Premawansa G, Thillainathan S, Fernando T, Kanapathippillai K, Wickremasinghe R, De Silva AD, Premawansa S. 2018. Is total serum nitrite and nitrate (NOx) level in dengue patients a potential prognostic marker of dengue hemorrhagic fever? Dis Markers. 2018:1–9.
  • Masood KI, Jamil B, Rahim M, Islam M, Farhan M, Hasan Z. 2018. Role of TNF α, IL-6 and CXCL10 in dengue disease severity. Iran J of Microbiol. 10(3):202–07.
  • Matsuura C, Moraes TL, Barbosa JB, Moss MB, Siqueira MAS, Mann GE, Neto ML, Brunini TMC, Mendes-Ribeiro AC. 2012. Nitric oxide activity in platelets of dengue haemorrhagic fever patients: the apparent paradoxical role of ADMA and l-NMMA. Trans R Soc Trop Med Hyg. 106(3):174–79.
  • Mendes-Ribeiro AC, Moss MB, Siqueira MA, Moraes TL, Ellory JC, Mann GE, Brunini TM. 2008. Dengue fever activates the L-arginine-nitric oxide pathway: an explanation for reduced aggregation of human platelets. Clin Exp Pharmacol Physiol. 35(10):1143–46.
  • Minhas R, Bansal Y, Bansal G. 2019. Inducible nitric oxide synthase inhibitors: a comprehensive update. Med Res Rev. 40(3):823–55.
  • Moreira ST, Cardoso DM, Fonzar UJV, Moliterno RA, Moliterno RA. 2008. The possible protective role of the Il6-174GC genotype in dengue fever. Open Trop Med J. 1(1):87–91.
  • Narayan R, Tripathi S. 2020. Intrinsic ADE: the dark side of antibody dependent enhancement during dengue infection. Front Cell Infect Microbiol. 10:580096.
  • Nikkari ST, Määttä KM, Kunnas TA. 2015. Functional inducible nitric oxide synthase gene variants associate with hypertension: a case–control study in a Finnish population – the TAMRISK Study. Medicine. 94(46):e1958.
  • Noponen-Hietala N, Virtanen I, Karttunen R, Schwenke S, Jakkula E, Li H, Merikivi R, Barral S, Ott J, Karppinen J, et al. 2005. Genetic variations in IL6 associate with intervertebral disc disease characterized by sciatica. Pain. 114(1):186–94.
  • Pan American Health Organization. Reported cases of Dengue fever in the Americas. [accessed 2022 March16]. https://www3.paho.org/data/index.php/en/mnu-topics/indicadores-dengue-en/dengue-nacional-en/252-dengue-pais-ano-en.html?start=1.
  • Paul WE, Zhu J. 2010. How are TH 2-type immune responses initiated and amplified? Nat Rev Immunol. 10(4):225–35.
  • Priyadarshini D, Gadia RR, Tripathy A, Gurukumar KR, Bhagat A, Patwardhan S, Mokashi N, Vaidya D, Shah PS, Cecilia D, et al. 2010. Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study. PloS One. 5(1):e8709.
  • Rathakrishnan A, Wang SM, Hu Y, Khan AM, Ponnampalavanar S, Lum LCS, Manikam R, Sekaran SD. 2012. Cytokine expression profile of dengue patients at different phases of illness. PloS One. 7(12):e52215.
  • Saravia J, Chapman NM, Chi H. 2019. Helper T cell differentiation. Cell Mol Immunol. 16(7):634–43.
  • Shreshtha S, Sharma P, Kumar P, Sharma R, Singh SP. 2018. Nitric oxide: it’s role in immunity. J Clin Diagn Res. 12(7): BE01–BE05.
  • Takhampunya R, Padmanabhan R, Ubol S. 2006. Antiviral action of nitric oxide on dengue virus type 2 replication. J Gen Virol. 87(10):3003–11.
  • Tanaka T, Narazaki M, Kishimoto T. 2014. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 6(10):a016295.
  • TramontiniGomes de Sousa Cardozo F, Baimukanova G, Lanteri MC, Keating SM, Ferreira FM, Heitman J, Pannuti CS, Pati S, Malta Romano C, Cerdeira Sabino E, et al. 2017. Serum from dengue virus-infected patients with and without plasma leakage differentially affects endothelial cells barrier function in vitro. PloS One. 12(6): e0178820.
  • Tran L, Radwan I, Minh LHN, Low SK, Hashan MR, Gomaa MD, Abdelmongy M, Abdelaziz AI, Mohamed A, Tawfik GM, et al. 2021. Role of cytokines produced by T helper immune-modulators in dengue pathogenesis: a systematic review and meta-analysis. Acta Trop. 216:105823.
  • Wellekens K, Betrains A, De Munter P, Peetermans W. 2020. Dengue: current state one year before WHO 2010 – 2020 goals. Acta Clin Belg. 77(2):436–44.
  • WHO – World Health Organization. 1997. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. Second edition. World Health Organization [accessed 2022 March16]. https://apps.who.int/iris/handle/10665/41988.
  • WHO – World Health Organization. 2009. Dengue: guidelines for diagnosis, treatment, prevention and control. New edition. Geneva: World Health Organization [accessed 2022 March 16]. https://apps.who.int/iris/handle/10665/44188.
  • Wilder-Smith A, Ooi E-E, Horstick O, Wills B. 2019. Dengue. The Lancet. 393(10169):350–63.
  • Xue Q, Yan Y, Zhang R, Xiong H. 2018. Regulation of iNOS on immune cells and its role in diseases. Int J Mol Sci. 19(12):3805.
  • Zhang Y, Li C, Li K, Liu L, Jian Z, Gao T. 2011. Analysis of inducible nitric oxide synthase gene polymorphisms in vitiligo in Han Chinese people. Plos One. 6(12):e27077.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.